How deadly is Diabetes?

Cé chomh marfach is atá diaibéiteas?

Is galar tromchúiseach é diaibéiteas agus d'fhéadfadh sé a bheith marfach.

De réir Eagraíocht Sláinte an Domhain (WHO), is é diaibéiteas an chúis dhíreach le níos mó ná 1.5 milliún bás in aghaidh na bliana, agus is fachtóir riosca mór é do ghalair eile mar galar cardashoithíoch, stróc, agus teip duáin.

Sa bhliain 2019, ba é diaibéiteas an naoú príomhchúis báis ar fud an domhain, agus meastar go raibh 1.5 milliún bás go díreach mar gheall ar an galar.

Mar sin féin, is dócha go bhfuil líon na mbásanna is féidir a chur i leith diaibéiteas i bhfad níos airde, toisc nach ndéantar é a thuairisciú go minic mar chúis báis.

Chomh maith le héifeachtaí díreacha na diaibéiteas, d'fhéadfadh an galar go mbeadh deacrachtaí éagsúla ann a d'fhéadfadh a bheith ina bhagairt ar shaol.

I measc na deacrachtaí seo tá galar croí, stróc, easpa duáin, damáiste néaróg, agus caillteanas amhairc.

Tá daoine a bhfuil diaibéiteas orthu i mbaol níos airde freisin ionfhabhtuithe a fhorbairt agus go bhfaigheann siad leigheas níos moille ar ghortú, rud a d'fhéadfadh go dtiocfadh deacrachtaí tromchúiseacha agus fiú bás.

Tá sé tábhachtach a thabhairt faoi deara gur féidir na rioscaí a bhaineann le diaibéiteas a laghdú go suntasach le bainistíocht agus le cóireáil chuí.

Áirítear leis seo rialú maith siúcra fola a choinneáil, seiceálacha rialta a dhéanamh, agus fachtóirí riosca eile mar bhrú fola ard agus leibhéil cholesterol a bhainistiú.

Tríd diaibéiteas a bhainistiú go héifeachtach, is féidir le daoine aonair a mbaol go dtarlóidh deacrachtaí a laghdú agus a dtorthaí sláinte foriomlán a fheabhsú.

Tagairtí

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Lin YP, Lu TH: Trends in death rate from diabetes according to multiple-cause-of-death differed from that according to underlying-cause-of-death in Taiwan but not in the United States, 1987-2007. J Clin Epidemiol. 2012, 65 (5): 572-6.

Zhu M, Li J, Li Z, Luo W, Dai D, Weaver SR, Stauber C, Luo R, Fu H: Mortality rates and the causes of death related to diabetes mellitus in Shanghai Songjiang District: an 11-year retrospective analysis of death certificates. BMC Endocr Disord. 2015, 15 (): 45.

McFarland KF, Hemaya E: Neonatal mortality in infants of diabetic mothers. Diabetes Care. , 8 (4): 333-6.

Tilghman J: Obesity and diabetes in African American women. ABNF J. , 14 (3): 66-8.

Will JC, Casper M: The contribution of diabetes to early deaths from ischemic heart disease: US gender and racial comparisons. Am J Public Health. 1996, 86 (4): 576-9.

Shigeta Y, Kikkawa R, Kobayashi N, Katabami J: A community study of diabetes in a population with a high diabetes mortality rate. Tohoku J Exp Med. 1983, 141 Suppl (): 257-60.

Danion F, Letscher-Bru V, Guitard J, Sitbon K, Dellière S, Angoulvant A, Desoubeaux G, Botterel F, Bellanger AP, Gargala G, Uhel F, Bougnoux ME, Gerber V, Michel J, Cornu M, Bretagne S, Lanternier F: Coronavirus Disease 2019-Associated Mucormycosis in France: A Rare but Deadly Complication. Open Forum Infect Dis. 2022, 9 (2): ofab566.

Diúltú freagrachta: leighis

Cuirtear an suíomh gréasáin seo ar fáil chun críocha oideachais agus faisnéise amháin agus ní sholáthraíonn sé comhairle leighis nó seirbhísí gairmiúla.

Níor cheart an t-eolas a chuirtear ar fáil a úsáid chun fadhb sláinte nó galar a dhiagnóisiú nó a chóireáil, agus ba cheart dóibh siúd atá ag lorg comhairle leighis phearsanta dul i gcomhairle le dochtúir ceadúnaithe.

Tabhair faoi deara le do thoil go bhfuil an líonra néarónach a ghineann freagraí ar na ceisteanna, míchruinn go háirithe nuair a bhaineann sé le hábhar uimhriúil. Mar shampla, líon na ndaoine a ndearnadh diagnóis orthu le galar ar leith.

Déan comhairle do dhochtúir nó do sholáthraí sláinte cáilithe eile i gcónaí maidir le riocht leighis. Ná déan neamhaird ar chomhairle leighis ghairmiúil ná déileáil leis mar gheall ar rud éigin a léigh tú ar an suíomh Gréasáin seo. Má cheapann tú go bhféadfadh éigeandáil leighis a bheith agat, glaoigh ar 911 nó téigh go dtí an seomra éigeandála is gaire láithreach. Ní chruthaíonn an suíomh Gréasáin seo ná a úsáid aon chaidreamh dochtúir-othar. Ní dhéanann BioMedLib ná a chuid fostaithe, ná aon ranníocóir leis an suíomh Gréasáin seo aon ionadaíochtaí, sainráite nó intuigthe, maidir leis an bhfaisnéis a sholáthraítear anseo ná a úsáid.

Diúltú freagrachta: cóipchirt

Soláthraíonn an Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (an DMCA) aisíocaíocht do úinéirí cóipchirt a chreideann go sáraíonn ábhar atá le feiceáil ar an Idirlíon a gcearta faoi dhlí cóipchirt na Stát Aontaithe.

Má chreideann tú go dea-chreidimh go sáraíonn aon ábhar nó ábhar a chuirtear ar fáil i ndáil lenár suíomh Gréasáin nó lenár seirbhísí do chóipcheart, féadfaidh tú (nó do ghníomhaire) fógra a sheoladh chugainn ag iarraidh an t-ábhar nó an t-ábhar a bhaint, nó rochtain air a bhac.

Ní mór fógraí a sheoladh i scríbhinn trí ríomhphost (féach an rannán "Contact" le haghaidh seoladh ríomhphoist).

Éilíonn an DMCA go gcuimsíonn do fhógra faoi shárú cóipchirt líomhain an fhaisnéis seo a leanas: (1) cur síos ar an saothar cóipchirt atá ina ábhar don shárú líomhain; (2) cur síos ar an ábhar líomhain atá ag sárú líomhain agus faisnéis leordhóthanach chun ligean dúinn an t-ábhar a aimsiú; (3) faisnéis teagmhála duit, lena n-áirítear do sheoladh, uimhir theileafóin agus seoladh ríomhphoist; (4) ráiteas uait go bhfuil creideamh maith agat nach bhfuil an t-ábhar ar an mbealach a bhfuil gearán á dhéanamh air údaraithe ag úinéir cóipchirt, nó a ghníomhaire, nó ag oibriú aon dlí;

(5) ráiteas uait, arna shíniú faoi phionós perjury, go bhfuil an t-eolas sa fhógra cruinn agus go bhfuil an t-údarás agat na cóipchearta a éilítear a shárú a fhorfheidhmiú;

agus (6) síntiús fisiciúil nó leictreonach úinéir an chóipchirt nó duine údaraithe chun gníomhú thar ceann úinéir an chóipchirt.

D'fhéadfadh moill a bheith ar phróiseáil do ghearán mura gcuirfidh tú an t-eolas thuas go léir san áireamh.

Cumarsáid

Seol ríomhphost dúinn le haon cheist / moladh le do thoil.

How deadly is diabetes?

Diabetes is a serious and potentially deadly disease.

According to the World Health Organization (WHO), diabetes is the direct cause of over 1.5 million deaths per year, and it is a major risk factor for other diseases such as cardiovascular disease, stroke, and kidney failure.

In 2019, diabetes was the ninth leading cause of death globally, with an estimated 1.5 million deaths directly attributed to the disease.

However, the number of deaths attributable to diabetes is likely much higher, as it is often underreported as a cause of death.

In addition to the direct effects of diabetes, the disease can also lead to various complications that can be life-threatening.

These complications include heart disease, stroke, kidney failure, nerve damage, and vision loss.

People with diabetes are also at a higher risk of developing infections and experiencing slower wound healing, which can lead to severe complications and even death.

It is important to note that with proper management and treatment, the risks associated with diabetes can be significantly reduced.

This includes maintaining good blood sugar control, regular check-ups, and managing other risk factors such as high blood pressure and cholesterol levels.

By managing diabetes effectively, individuals can reduce their risk of developing complications and improve their overall health outcomes.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.